+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years - 75Years
All Genders
ID06927297

Phase 1 Clinical Trial of an Engineered Mitochondrial Vaccine to Assess Safety and Preliminary Effectiveness in Adults With Advanced Solid Tumors

Led by West China Hospital · Updated on 2026-03-17

12

Participants Needed

1

Research Sites

69 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating an engineered mitochondrial vaccine in patients with advanced solid tumors to assess its safety, tolerability, and early signs of therapeutic effect. This phase 1, dose-escalation clinical trial aims to address the urgent need for new treatments in advanced malignant solid tumors, which currently have limited options and poor outcomes. The study leverages mitochondria engineered to express tumor-specific antigens to activate the immune system against cancer cells. Participants are assigned to one of four dose groups 25, 50, 100, or 200 micrograms per dose and receive subcutaneous injections of the vaccine following a prime-boost schedule. This regimen includes three primary immunization doses, one booster dose, and personalized treatment afterward. The study carefully monitors escalating doses to evaluate safety and preliminary anti-tumor activity. During the trial, participants undergo regular assessments including monitoring for adverse events over one year, and evaluation of tumor response, disease control, progression-free survival, and overall survival up to six months to one year. Various laboratory tests and physical examinations ensure organ function and overall health throughout the study. The total participation duration depends on individual response and follow-up schedules, with close safety monitoring provided by the researchers.

CONDITIONS

Brief Title

Phase I Study of the Safety, Tolerability, and Efficacy of an Engineered Mitochondrial Vaccine in Advanced Solid Tumors

Research Team

X

Xingchen Peng, Ph.D

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here